Key result
High-dose corticosteroid pulse therapy combined with mechanical circulatory support led to rapid resolution of cardiogenic shock and recovery of cardiac function in three young adults with MIS-A.
Why the study?
Multisystem inflammatory syndrome associated with SARS-CoV-2 infection can present with myocarditis complicated by cardiogenic shock, but few case reports describe MIS in adults.
Case Report (n=3)
No
High-dose corticosteroid pulse therapy and mechanical circulatory support appear effective in managing fulminant myocarditis and cardiogenic shock associated with SARS-CoV-2 MIS-A.
Answers are grounded in this paper and cite their sources.
May support steroids plus MCS in refractory MIS-A shock; hypothesis-generating and should not change practice.
BACKGROUND: Multisystem inflammatory syndrome (MIS) associated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is a life-threatening condition first described in children (MIS-C). It is characterized by a hyperinflammatory state that involves the cardiovascular, gastrointestinal, dermatologic, and neurologic systems without severe respiratory system involvement. Myocarditis is one of the cardiovascular presentations of MIS that might be complicated with cardiogenic shock. There are few case reports describing SARS-CoV-2-related MIS in adults (MIS-A). CASE SUMMARY: Three cases of healthy young adults diagnosed with severe acute respiratory syndrome-CoV-2 related (MIS-A). The main presentation was cardiogenic shock secondary to histologically proven myocarditis, which resolved rapidly after initiation of medical therapy including anti-inflammatory and immunosuppressive drugs. All the cases, however, required mechanical circulatory support (MCS) as a bridge to recovery. CONCLUSIONS: It appears reasonable to treat the patient with fulminant myocarditis in SARS-CoV-2-associated MIS-A with high-dose corticosteroid "pulse" therapy in order to suppress the inflammatory response and MCS to correct initial metabolic derangement and reestablish/maintain vital organ perfusion. Addition of IV immunoglobulin and other immunomodulators should be assessed in a case-by-case basis especially considering the associated cost resource allocation.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a case report in Multisystem Inflammatory Syndrome in Adults (MIS-A) associated with COVID-19 (n=3). High-dose corticosteroid pulse therapy and mechanical circulatory support was evaluated on Resolution of cardiogenic shock and recovery of cardiac function. High-dose corticosteroid pulse therapy combined with mechanical circulatory support led to rapid resolution of cardiogenic shock and recovery of cardiac function in three young adults with MIS-A.
Synapse has enriched 10 related papers. Consider them for comparative context: